Exchange: NASDAQ·Updated 06:27 PM EST

ATYR News

News
all
press releases
aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
More News
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven research firms that are covering the stock, Marketbeat Ratings...
MarketBeat
aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recomm...
MarketBeat
Wall Street Zen raised shares of aTyr Pharma from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat
aTyr Pharma (NASDAQ:ATYR) CEO Sanjay Shukla outlined the company's strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the...
MarketBeat
aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of aTyr Pharma in a research report issued on Friday, March 6th...
MarketBeat
(RTTNews) - aTYR PHARMA INC (ATYR) reported Loss for fourth quarter of -$13.96 million...
Nasdaq News: Markets
aTyr Pharma (NASDAQ:ATYR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by...
MarketBeat
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat.com...
MarketBeat

Advertisement|Remove ads.